Skip to content
Screener

Total debt at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$13.51B-22.9%
Stryker logo
StrykerSYK
$14.19B-15.2%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
$48.37M+8.2%
Axogen logo
AxogenAXGN
$20.07M-70.6%
Globus Medical logo
Globus MedicalGMED
$112.25M-7.6%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
$63.59M+1,750%

Other financials

Income statement

See full
Revenue$418.8M+0.8%
Gross profit$219.7M+5.0%
Operating income$19.3M+104%
Net income$4.5M+101%
EPS (diluted)$0.06+101%

Balance sheet

See full
Cash & equivalents$214.4M-1.6%
Total equity$1.0B+0.5%
Total assets$3.6B-2.8%

Cash flow

See full
Operating cash flow$22.8M+156%
CapEx$12.3M-38.9%
Free cash flow$10.5M+193%

Valuation

See full
Market cap$1.33B+38.0%
Enterprise value$3.08B+16.2%
P/S0.8×+0.2×

Profitability

See full
Gross margin52.5%-0.1pp
Operating margin2.6%+1.3pp
Net margin-0.4%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-0.7%
Debt / equity1.9×+0.1×
Current ratio3.6×+2.4×

Where this comes from

Calculated from Integra LifeSciences’s reported figures.

Plus components not separately reported this period.

The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026. Open the filing →

Filed
Jul 29, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000917520-26-000058

FAQ

What is Integra LifeSciences's total debt?
Integra LifeSciences (IART) reported total debt of $1.97B in Q2 2026.
How has Integra LifeSciences's total debt changed year-over-year?
Integra LifeSciences's total debt increased by 3.2% year-over-year, from $1.9B to $1.97B.
What is the long-term trend for Integra LifeSciences's total debt?
Over 5 years (2020 to 2025), Integra LifeSciences's total debt has grown at a 13.0% compound annual growth rate (CAGR), from $1.03B to $1.91B.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.

Ask your AI about Integra LifeSciences's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude